Avoidance of polypharmacy and excessive blood pressure control is associated with improved renal function in older patients

References

• Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–2874
   PubMed Web of Science ®Google Scholar
• Simon SR, Chan KA, Soumerai SB, et al. Potentially inappropriate medication use by elderly persons in U.S. Health Maintenance Organizations, 2000–2001. J Am Geriatr Soc. 2005;53(2):227–232
   PubMed Web of Science ®Google Scholar
• Der Mesropian PJ, Kalamaras JS, Eisele G, Phelps KR, Asif A, Mathew RO. Long-term outcomes of community-acquired versus hospital-acquired acute kidney injury: A retrospective analysis. Clin Nephrol. 2014;81(3):174–184
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
   PubMed Web of Science ®Google Scholar
• Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;(133):1–8
   PubMedGoogle Scholar
• Lim WK, Woodward MC. Improving medication outcomes in older people. Aust J Hosp Pharm. 1999;29(2):103–107
   Google Scholar
• Willlams CM. Using medications appropriately in older adults. Am Fam Physician. 2002;66(10):1917–1924
   PubMed Web of Science ®Google Scholar
• Richardson K, Bennett K, Kenny RA. Polypharmacy including falls risk-increasing medications and subsequent falls in community-dwelling middle-aged and older adults. Age Ageing. 2015;44(1):90–96
   PubMed Web of Science ®Google Scholar
• Beers MH, ed. Section 1: Basics of geriatric care. Clinical pharmacology. In: The Merck Manual of Geriatrics. 3rd ed., Chapter 6. Whitehouse Station, NJ: Merck Sharp & Dohme Corp.; 2005:54–74
   Google Scholar
• Corcoran ME. Polypharmacy in the older patient with cancer. Cancer Control. 1997;4(5):419–428
   PubMedGoogle Scholar
• Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–1116
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631
   PubMed Web of Science ®Google Scholar
• Marcum ZA, Fried LF. Aging and antihypertensive medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):449–456
   PubMed Web of Science ®Google Scholar
• Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009;8(6):669–681
   PubMed Web of Science ®Google Scholar
• James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520
   PubMed Web of Science ®Google Scholar
• Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;16(1):14–26
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, et al.; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358(18):1887–1898
   PubMed Web of Science ®Google Scholar
• Tinetti ME, Han L, Lee DS, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–595
   PubMed Web of Science ®Google Scholar
• Kovesdy CP, Bleyer AJ, Molnar MZ, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: A cohort study. Ann Intern Med. 2013;159(4):233–242
   PubMed Web of Science ®Google Scholar
• Simm JJ, Shi J, Kovesdy CP, Kalantar-Zadeh K, Jacobsen SJ. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol. 2014;64(6):588–597
   PubMed Web of Science ®Google Scholar
• Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370
   PubMed Web of Science ®Google Scholar
• Talabani B, Zouwail S, Pyart RD, Meran S, Riley SG, Phillips AO. Epidemiology and outcome of community-acquired acute kidney injury. Nephrology (Carlton). 2014;19(5):282–287
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305
   PubMed Web of Science ®Google Scholar